Bingqing Cao Ling Cao
10.3389/fcimb.2023.1163341
Front Cell Infect Microbiol
2023 Jun 21;13:1163341.
acinetobacter baumannii extensively drug-resistant pneumonia polymyxin b spinal muscular atrophy
CC BY
https://pubmed.ncbi.nlm.nih.gov/37415826/
Acinetobacter baumannii Muscular Atrophy, Spinal / complications Muscular Atrophy, Spinal / drug therapy Neurodegenerative Diseases Pneumonia / drug therapy
Acinetobacter baumannii Muscular Atrophy, Spinal / complications Muscular Atrophy, Spinal / drug therapy Neurodegenerative Diseases Pneumonia / drug therapy Review Case Reports Anti-Bacterial Agents / therapeutic use Child Humans Polymyxin B / therapeutic use Polymyxin B Anti-Bacterial Agents
PMC10321296
37415826
Case Report: A case of spinal muscular atrophy with extensively drug-resistant Acinetobacter baumannii pneumonia treated with nebulization combined with intravenous polymyxin B: experience and a literature review
2023